Within the intricate architecture of brain cells, a fundamental process known as endocytosis continuously facilitates the uptake of essential materials from the surrounding extracellular environment, encompassing vital nutrients, crucial signaling molecules, and even discarded segments of the cell’s own outer membrane. This dynamic cellular activity underpins fundamental cognitive functions such as learning and memory, while also playing a pivotal role in the ongoing maintenance and health of neuronal networks. Now, a groundbreaking investigation spearheaded by researchers at Penn State University has illuminated a previously unrecognized structural component within neurons that appears to exert significant control over this vital endocytic machinery. This newly identified entity, christened the membrane-associated periodic skeleton (MPS), is characterized as a sophisticated protein lattice situated just beneath the neuron’s plasma membrane.
The scientific community has long sought to unravel the complex molecular mechanisms governing endocytosis, recognizing its profound connection to the onset and progression of neurodegenerative disorders. The research, detailed in the esteemed journal Science Advances, posits that the MPS functions as a critical gatekeeper, dictating the flow of substances into the neuron through nearly every major pathway of endocytosis. Composed of meticulously arranged, repeating protein rings, the MPS was previously understood primarily for its role in maintaining the structural integrity and characteristic shape of neurons. However, this latest research dramatically expands our understanding, revealing its active and dynamic participation in regulating both the location and the timing of material entry into the cell.
Dr. Ruobo Zhou, an associate professor at Penn State with affiliations in chemistry, biochemistry and molecular biology, and biomedical engineering, who served as the study’s corresponding author, emphasized the years of dedicated effort to decipher this intricate molecular process. "For many, many years we have been trying to understand this molecular mechanism, what kind of machinery will help to facilitate this process, because it’s connected to neurodegenerative diseases," Dr. Zhou stated. He further elaborated on the pathological consequences when endocytosis falters, noting that disruptions in nutrient uptake and regulation can lead to the aberrant accumulation of misfolded proteins within the brain, a defining characteristic of devastating neurodegenerative conditions like Alzheimer’s and Parkinson’s diseases.
Dr. Zhou himself was instrumental in the initial discovery of the MPS in 2013 during his postdoctoral work at Harvard University. At that juncture, the prevailing scientific consensus viewed the MPS as a largely passive structural element, providing internal support to the neuron. The current investigation, however, employing cutting-edge super-resolution imaging techniques on laboratory-cultured neurons, has compellingly demonstrated that the MPS operates with a far more sophisticated agency, acting akin to a highly efficient cellular traffic controller, orchestrating the dynamics of all major forms of endocytosis.
To meticulously observe cellular uptake at the nanoscale, the research team leveraged advanced super-resolution microscopy, a powerful tool capable of resolving structures on the order of nanometers – a scale approximately 10,000 times smaller than the diameter of a human hair. Their experimental approach involved cultivating neurons in controlled laboratory settings and strategically engineering specific proteins within these cells to serve as traceable markers.
Subsequently, the researchers subjected the neurons to a variety of molecular stimuli, meticulously documenting the cells’ absorption processes while ensuring the integrity of the MPS. Crucially, they also manipulated the MPS structure itself, either by inducing targeted damage or by reinforcing specific regions, thereby enabling them to directly observe how neuronal behavior was altered in response to these structural modifications. The results were striking: when the MPS was experimentally compromised, neurons exhibited a markedly accelerated rate of material absorption. This observation provided definitive evidence that the MPS normally functions to temper the pace of endocytosis, preventing an excessive influx of substances into the cell.
Furthermore, the study uncovered a potentially self-perpetuating mechanism where the MPS can contribute to its own degradation. The heightened rate of endocytosis, triggered by an impaired MPS, paradoxically led to a weakening of the lattice structure itself. This initiated a positive feedback loop: increased cellular uptake stimulated intracellular molecular signaling cascades that, in turn, directed specific proteins within the neuron to cleave and dismantle portions of the MPS. This structural breakdown consequently opened up additional entry points, facilitating an even greater influx of nutrients and other molecular entities.
"We discovered that this membrane skeleton is actively regulating the nutrient uptake process of neurons," Dr. Zhou explained, likening its function to a vigilant gatekeeper. "You can think of it as a gatekeeper, guarding this physical barrier to not allow nutrient uptake to happen. When a neuron needs to take in a specific nutrient, this gatekeeper will open the gates and let it in." Dr. Zhou further posited that this inherent flexibility in the MPS likely allows neurons to augment their activity levels when rapid responses are required. However, he cautioned that this same adaptive mechanism could become detrimental if its regulatory control is compromised.
The potential implications of this discovery for Alzheimer’s disease were a significant focus of the research. To investigate this link, the scientists devised cellular models designed to mimic the early pathological stages observed in Alzheimer’s disease. This involved inducing neurons to overproduce amyloid precursor protein (APP), a protein widely recognized as a key molecular marker associated with the disease.
The experimental manipulation revealed that weakening the MPS led to a more rapid uptake of APP by the neurons. Once inside the cellular environment, APP is enzymatically cleaved into amyloid-beta 42 (Aβ42), a particularly toxic fragment strongly implicated in the pathogenesis of Alzheimer’s disease. Neurons exhibiting a compromised MPS demonstrated a progressive accumulation of this harmful molecule and displayed an increased prevalence of cellular damage markers, indicative of impending cell death.
Jinyu Fei, a graduate student in the chemistry department and the lead author of the study, elaborated on these findings. "We created a model which is very much like Alzheimer’s disease and found that in some aging neurons, or neurons under pathologic conditions, the endocytosis of toxic proteins was enhanced, which caused stressing conditions, ultimately leading to neuron deaths," Fei stated.
These compelling results strongly suggest that the MPS may serve as a crucial protective barrier within neurons, primarily by moderating the uptake of APP and thereby limiting the detrimental accumulation of toxic amyloid species. Given that the structural integrity of the MPS is known to decline with advanced age and in the context of neurodegenerative diseases, its deterioration could potentially initiate a vicious cycle. This cycle could involve amplified amyloid production, further structural weakening of the MPS, and ultimately, neuronal demise.
The researchers propose that strategies aimed at preserving or reinforcing the structural integrity of the MPS could represent a novel therapeutic avenue for slowing the progression of neurodegeneration. "We think this could open the door for future therapies such as a protein target for neurodegenerative disease treatment," Fei concluded. "Preserving or stabilizing the MPS might offer a way to slow the early, hidden cellular changes that precede Alzheimer’s symptoms."
The collaborative research effort involved contributions from Yuanmin Zheng, a doctoral candidate in biomedical engineering; Caden LaLonde, a fourth-year undergraduate student pursuing a degree in biochemistry and molecular biology; and Yuan Tao, a graduate student at Penn State’s Huck Institutes of Life Sciences. This groundbreaking work was supported by funding from the National Institutes of Health.
About the Author
